文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

外科重症监护病房有创通气撤机后序贯经鼻高流量氧疗的特点及失败危险因素

[Characteristics and failure risk factors of sequential high-flow nasal cannula oxygen therapy after weaning from invasive ventilation in patients of surgical intensive care unit].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2019-01-01
一句话结论外科ICU撤机后序贯HFNC失败率18.2%,SOFA评分、HFNC前BNP和HFNC 30分钟后心率是独立危险因素,回归模型预测失败AUC达0.962。

该研究回顾性分析北京大学人民医院外科ICU 2016年6月1日至2018年5月31日收治的99例有创通气撤机后序贯HFNC患者,比较HFNC成功组与失败组(18例,18.2%)的临床变量、呼吸治疗参数、呼吸与心脏变量及结局,并用Logistic回归分析失败独立危险因素、ROC曲线评估预测价值。结果显示失败组SOFA评分、HFNC前BNP、HFNC 30分钟后RR、HR、MAP更高,PaO2/FiO2更低;SOFA评分(OR=2.818)、HFNC前BNP(OR=1.002)、HFNC 30分钟后HR(OR=1.140)为独立危险因素,各危险因素及回归模型预测失败的AUC分别为0.840、0.859、0.860、0.962。提示并非所有撤机后序贯HFNC患者均能获益,可用上述指标识别失败高危者。

要点

  • 外科ICU有创通气撤机后序贯HFNC患者99例中18例(18.2%)治疗失败。
  • HFNC失败组SOFA评分4(3,5)vs 成功组2(1,3),P<0.01。
  • HFNC失败组HFNC前BNP 647.2(399.2,1331.3)ng/L vs 成功组127.2(55.2,369.5)ng/L,P<0.01。
  • HFNC 30分钟后失败组HR 105(97,107)bpm vs 成功组85(77,90)bpm,P<0.05。
  • SOFA评分、HFNC前BNP、HFNC 30分钟后HR为失败独立危险因素,回归模型预测AUC 0.962。

适用人群与场景

  • 2016年6月1日至2018年5月31日北京大学人民医院外科ICU收治的有创通气撤机后接受序贯HFNC的患者,共99例,男61例,中位年龄67.0(57.0,76.0)岁。

诊断标准与关键阈值

  • HFNC失败:原文定义为HFNC治疗失败,据此将患者分为HFNC成功组与HFNC失败组。

处置流程与药物剂量

  • 初始HFNC流量中位数50(50,60)L/min,吸入氧浓度(FiO2)0.50(0.40,0.60)。

研究设计与关键结果

  • 研究类型为回顾性分析,纳入99例外科ICU有创通气撤机后序贯HFNC患者,18例(18.2%)HFNC失败。
  • HFNC失败组SOFA评分4(3,5)vs 成功组2(1,3),P<0.01。
  • HFNC失败组HFNC前BNP 647.2(399.2,1331.3)ng/L vs 成功组127.2(55.2,369.5)ng/L,P<0.01。
  • HFNC 30分钟后失败组RR 26(22,28)次/min vs 成功组19(17,21)次/min,HR 105(97,107)bpm vs 85(77,90)bpm,MAP 104.3(101.7,110.7)mmHg vs 92.3(88.3,97.7)mmHg,PaO2/FiO2 207.3(185.8,402.8)mmHg vs 320.2(226.2,361.5)mmHg,均P<0.05。
  • 多因素Logistic回归:SOFA评分OR=2.818(P=0.022,β=1.036)、HFNC前BNP OR=1.002(P=0.033,β=0.002)、HFNC 30分钟后HR OR=1.140(P=0.032,β=0.131)为HFNC治疗失败的独立危险因素。
  • ROC曲线:SOFA、HFNC前BNP、HFNC 30分钟后HR、回归模型预测HFNC失败的AUC分别为0.840、0.859、0.860、0.962,均P<0.01。

证据类型、等级与局限

  • 证据类型:回顾性分析(单中心,北京大学人民医院外科ICU)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为HFNC是ICU常用氧疗方法之一,但并非所有有创机械通气撤机后序贯治疗的患者都能从中获益。
  • 作者认为SOFA评分、HFNC前BNP和HFNC 30分钟后HR是HFNC失败的独立危险因素,各独立危险因素及回归模型均可预测HFNC治疗成功。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the characteristics and failure risk factors of sequential high-flow nasal cannula oxygen therapy (HFNC) after weaning from invasive ventilation.

METHODS: The patients who received sequential HFNC after weaning from invasive ventilation admitted to surgical intensive care unit (ICU) of Peking University People's Hospital from June 1st 2016 to May 31st 2018 were retrospectively analyzed. Clinical variables, respiratory therapy parameters, respiratory variables, cardiac variables and outcomes were reviewed and analyzed. Treatment characteristics of HFNC after weaning was analyzed. Patients were divided into HFNC success group and HFNC failure group according to the failure of HFNC, and the differences between the two groups were compared. The independent risk factors of HFNC treatment failure were analyzed by Logistic regression analysis. The value of predictive treatment failure of risk factors and regression models were analyzed by receiver operating characteristic (ROC) curve.

RESULTS: A total of 99 patients were included, 61 men, and the median age was 67.0 (57.0, 76.0) years old. The medianinitial HFNC flow was 50 (50, 60) L/min, and inspired oxygen concentration (FiO2) was 0.50 (0.40, 0.60). Eighteen patients experienced HFNC failure (18.2%). Compared with the HFNC success group, the sequential organ failure assessment (SOFA) score in the HFNC failure group was higher [4 (3, 5) vs. 2 (1, 3), P < 0.01], B type natriuretic peptide (BNP) before HFNC therapy were significant higher [ng/L: 647.2 (399.2, 1 331.3) vs. 127.2 (55.2, 369.5), P < 0.01], and respiratory frequency (RR) and heart rate (HR) were significant faster, mean arterial pressure (MAP) was significant higher, oxygen index (PaO2/FiO2) was significant lower after 30 minutes HFNC treatment [RR (times/min): 26 (22, 28) vs. 19 (17, 21), HR (bpm): 105 (97, 107) vs. 85 (77, 90), MAP (mmHg, 1 mmHg = 0.133 kPa): 104.3 (101.7, 110.7) vs. 92.3 (88.3, 97.7), PaO2/FiO2 (mmHg): 207.3 (185.8, 402.8) vs. 320.2 (226.2, 361.5), all P < 0.05]. It was shown by multiple Logistic regression analysis that the SOFA score [odds ratio (OR) = 2.818, P = 0.022, β = 1.036], BNP before HFNC treatment (OR = 1.002, P = 0.033, β = 0.002) and HR after HFNC treatment 30 minutes (OR = 1.140, P = 0.032, β = 0.131) were independent risk factors for HFNC treatment failure. It was shown by ROC curve that the area under the ROC curve (AUC) for the prediction of HFNC failure was 0.840, 0.859, 0.860 and 0.962 for SOFA, BNP before HFNC treatment, HR after HFNC treatment 30 minutes, and regression model, all had good forecast values (all P < 0.01).

CONCLUSIONS: HFNC is one of the commonly used oxygen therapy methods in the ICU, but not all patients who are treated as a sequential therapy after invasive mechanical ventilation weaning can benefit from it. SOFA score, BNP before HFNC treatment and HR after 30 minutes HFNC treatment were independent risk factors of HFNC failure. Each independent risk factor and regression model can predict the success of HFNC treatment.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Zhao H, Luo J, Lyu J, et al. [Characteristics and failure risk factors of sequential high-flow nasal cannula oxygen therapy after weaning from invasive ventilation in patients of surgical intensive care unit]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 31315724. doi:10.3760/cma.j.issn.2095-4352.2019.06.006

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。